Chinese Medicine on Deferring Dialysis Initiation

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 875 participants.

Also called NCT02194946

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 875 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02194946
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02194946. Non-randomized; no masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2020-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Chinese Medicine on Deferring Dialysis Initiation
Acronym
C-MODDI
Condition
End-Stage Renal Disease
Intervention (Drug)
CM therapies
Intervention (Drug)
CKD-related management
Lead sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine (class: other)
Collaborator
Ministry of Science and Technology of the People´s Republic of China (class: other government)

Record details

Record id
cardio:ct-nct02194946
Content hash
a765df843dcf56f4cb844038698b30f0e74cccfea2dd2663c64073ed61d6fad9